Beyond Air Q2 revenue up 128% to $1.8M; net loss narrows; secures $32M financing

Beyond Air, Inc.

2026-Q2 EPS reported -$2.75 revenue$3,578,000

Revenue $1.8M (+128% YoY); net loss ($7.9M) ($1.25/share) vs. ($13.4M) ($5.67/share).
Secured $32M capital ($12M note, 15%, 24-month maturity + $20M equity line); proforma cash $22.9M, runway into 2027.
Appointed Bob Goodman (Board member) as Interim CCO; David Webster departed.
Updated FY2026 revenue guidance to $8-$10M; achieved MDSAP certification; patent allowance for Gen2 LungFit PH.
International distribution network expanded to 35 countries; Phase 1a UNO trial completed with median survival >23 months.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.